Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis

Overview of attention for article published in Frontiers in Pharmacology, September 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 7,432 followers.

Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis https://t.co/jSLHz0qtbA

RT @FrontPharmacol: New Research: Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis https://t.co/YtleM5XRUd #phar…

New Research: Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis https://t.co/YtleM5XRUd #pharmacology

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.